Publication | Closed Access

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

Aio/iag-kht Trial 1108Open-label Phase IiMedicinePathologyHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyCancer Research